Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-11-09 00:00:00 ET · period of report 2021-11-05 · accession 0001209191-21-063591 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-09 | 2021-11-05 | TVTX | ASELAGE STEVE | Dir | S - Sale+OE | $26.23 | -10.0K | 161.8K | -6% | -$262.3K |
| D | 2021-11-09 | 2021-11-05 | TVTX | ASELAGE STEVE | Dir | M - OptEx | $16.23 | +10.0K | 171.8K | +6% | +$162.3K |
| D | 2021-11-09 | 2021-11-05 | TVTX | ASELAGE STEVE | Dir | M - OptEx | $0.00 | -10.0K | 70.0K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | S | D | 10,000 | $26.23 | 161,794 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-05 | M | A | 10,000 | $16.23 | 171,794 | D | — | — | |
| 3 | Derivative | Employee stock option (right to buy) | 2021-11-05 | M | D | 10,000 | $0.00 | 70,000 | D | $16.23 · — to 2026-05-18 | 10,000 Common Stock | (F3) The stock option is fully vested and exercisable. |